Celcuity Inc. ( CELC) - Key Metrics
CELC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.44 | -$1.01 | -$1.01 |
| 2026Q1 | $0 | -$0.97 | -$1.01 | -$1.02 |
| 2025Q4 | $0 | -$0.97 | -$0.69 | -$0.69 |
| 2025Q3 | $0 | -$0.98 | -$1 | -$1 |
| 2025Q2 | $0 | -$1.04 | -$0.83 | -$0.83 |
CELC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -18.16 |
| 2026Q1 | 0% | -29.42 |
| 2025Q4 | 0% | -25.97 |
| 2025Q3 | 0% | -13.42 |
| 2025Q2 | 0% | -3.21 |
CELC
Price: $92
52 week price:
Earnings Per Share: -4.30 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 28600
Market Capitalization: 4.5 billion